Compounding that statistic, prior studies indicate some trans people at high risk for HIV transmission are hesitant to take ...

On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in ...

An FDA panel of experts has called for a loosening of regulations and expanding access to testosterone replacement therapy.

Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with ...

Clascoterone 5%, a topical anti-androgen drug indicated for male pattern hair loss, demonstrated significant hair regrowth ...